TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation

Journal of Neuroimmunology

Volumn 151, Issue 1-2, 2004, Pages 116-125

  Gimenez, Mary Ann T ^a   Sim, Julia E ^a   Russell, John H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocyte; Experimental autoimmune encephalomyelitis; Inflammation; Multiple sclerosis; T cell

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 1; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; ENCEPHALITIS; IMMUNOHISTOCHEMISTRY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

ADOPTIVE TRANSFER; ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, TRANSGENIC; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 2442547563     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.02.012     Document Type: Article

References (37)

1. Abrams S.I., Russell J.H. CD4+ T lymphocyte-induced target cell detachment. A model for T cell-mediated lytic and nonlytic inflammatory processes. Journal of Immunology. 146:1991;405-413
2. Ando D.G., Clayton J., Kono D., Urban J.L., Sercarz E.E. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cellular Immunology. 124:1989;132-143
3. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neuroscience. 4:2001;1116-1122
4. Barten D.M., Ruddle N.H. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. Journal of Neuroimmunology. 51:1994;123-133
5. Bevilacqua M.P. Endothelial-leukocyte adhesion molecules. Annual Review of Immunology. 11:1993;767-804
6. Brosnan C.F., Cannella B., Battistini L., Raine C.S. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology. 45:1995;S16-S21
7. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60-66
8. Cannella B., Raine C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. [see comments] Annals of Neurology. 37:1995;424-435
9. Carlos T.M., Schwartz B.R., Kovach N.L., Yee E., Rosso M., Osborn L.C., Chi-Rosso G., Newman B., Lobb R., Harlan J.M. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood. 76:1990;965
10. Cohen J.A., Essayan D.M., Zweiman B., Lisak R.P. Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cellular Immunology. 108:1987;203-213
11. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:1990;577-584
12. Eugster H.P., Frei K., Bachmann R., Bluethmann H., Lassmann H., Fontana A. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. European Journal of Immunology. 29:1999;626-632
13. Graesser D., Mahooti S., Madri J.A. Distinct roles of matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchuma during experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 109:2000;121-131
14. Hochman P.S., Majeau G.R., Mackay F., Browning J.L. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands. Journal of Inflammation. 46:1995;220-236
15. Hurwitz A.A., Lyman W.D., Guida M.P., Calderon T.M., Berman J.W. Tumor necrosis factor alpha induces adhesion molecule expression on human fetal astrocytes. Journal of Experimental Medicine. 176:1992;1631-1636
16. Irani D.N., Griffin D.E. Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitis. Journal of Immunological Methods. 139:1991;223-231
17. Korner H., Riminton D.S., Strickland D.H., Lemckert F.A., Pollard J.D., Sedgwick J.D. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. Journal of Experimental Medicine. 186:1997;1585-1590
18. Lee S.J., Benveniste E.N. Adhesion molecule expression and regulation on cells of the central nervous system. Journal of Neuroimmunology. 98:1999;77-88
19. Li Y.Y., Li X.M. The IAP family: endogenous caspase inhibitors with multiple biological acitivities. Cell Research. 10:2000;169-177
20. Lucchinetti C.F., Brueck W., Rodriguez M., Lassmann H. Multiple sclerosis: lessons from neuropathology. Semin. Neurol. 18:1998;337
21. Miller D.H., Khan O.A., Sheremata W.A., Blumhardt L.D., Rice G.P.A., Libonati M.A., Willmer-Hulme A.J., Dalton C.M., Miszkiel K.A., O'Connor P.W. A controlled trial of natalizumab for relapsing multiple sclerosis. The New England Journal of Medicine. 348:2003;15-23
22. Moore G.R., McCarron R.M., McFarlin D.E., Raine C.S. Chronic relapsing necrotizing encephalomyelitis produced by myelin basic protein in mice. Laboratory Investigation. 57:1987;157-167
23. Neumann B., Machleidt T., Lifka A., Pfeffer K., Vestweber D., Mak T.W., Holzmann B., Kronke M. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. Journal of Immunology. 156:1996;1587-1593
24. Osborn L.C., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., Lobb R. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 59:1989;1203
25. Pakala S.V., Chivetta M., Kelly C.B., Katz J.D. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. Journal of Experimental Medicine. 189:1999;1053-1062
26. Paul N.L., Ruddle N.H. Lymphotoxin. Annual Review of Immunology. 6:1988;407-438
27. Prineas J.W. The Neuropathology of Multiple Sclerosis. 1985;Elsevier, New York
28. Rosenman S.J., Shrikant P., Dubb L., Benveniste E.N., Ransohoff R.M. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. Journal of Immunology. 154:1995;1888-1899
29. Sabelko K.A., Kelly K.A., Nahm M.H., Cross A.H., Russell J.H. Fas and fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. Journal of Immunology. 159:1997;3096-3099
30. Soilu-Hanninen H., Roytta M., Salmi A., Salonen R. Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis. Journal of Neuroimmunology. 72:1997;95-105
31. Suvannavejh G.C., Lee H.-O., Padilla J., Dal Canto M.C., Barrett T.A., Miller S.D. Divergent roles for p55 and p75 Tumor Necrosis Facto Receptors in the pathogenesis of MOG 35-55-induced experimental autoimmune encephalomyelitis. Cellular Immunology. 205:2000;24-33
32. Vajkoczky P., Laschinger M., Engelhardt B. Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. Journal of Clinical Investigation. 108:2001;557-565
33. Vanderbark A.A., Vainiene M., Celnik B., Hashim G., Offner H. TCR peptide therapy decreases the frequency of encephalitogenic T cells in the periphery and the central nervous system. Journal of Neuroimmunology. 39:1992;251-260
34. Van Oosten B.W., Barkhof F., Truyen L., Boringa J.B., Bertelsmann F.W., Von B.B. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology. 47:1996;1531-1534
35. Vassali P. The pathophysiology of tumor necrosis factor. Annual Review of Immunology. 10:1992;411-452
36. Willenborg D.O., Fordham N.C., O'Brien W.B., Cowden W.B., Ramshaw I.A. Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Research in Immunology. 149:1998;804-810. (discussion 849-850, 855-860)
37. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 356:1992;63-66